We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AVTOZMA
Australian Public Assessment Report
Device/Product Name
AVTOZMA
Active ingredients
tocilizumab
AusPAR Date
Published
Submission Number
PM-2024-00865-1-3
Submission Type
New biosimilar (to ACTEMRA)
Decision
Approved